Rackham; Mark David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rackham; Mark David.The latest application filed is for "bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor".

Company Profile

13.10.9

Rackham; Mark David - Cambridge GB
Rackham; Mark David - Stevenage GB
Rackham; Mark David - Welwyn Garden City GB
Rackham; Mark David - Welwyn Garden GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Muscarinic agonists Grant 11,324,738 - Brown , et al. May 10, 2	2022-05-10
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor Grant 10,961,225 - Brown , et al. March 30, 2	2021-03-30
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor App 20200325118 - Brown; Giles Albert ; et al.	2020-10-15
Conjugates comprising RIPK2 inhibitors Grant 10,781,205 - Casillas , et al. Sept	2020-09-22
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor Grant 10,689,368 - Brown , et al.	2020-06-23
Muscarinic Agonists App 20200129496 - Brown; Giles Albert ; et al.	2020-04-30
Muscarinic agonists Grant 10,548,884 - Brown , et al. Fe	2020-02-04
Novel Compounds App 20190382381 - CASILLAS; Linda N. ; et al.	2019-12-19
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor App 20190337925 - Brown; Giles Albert ; et al.	2019-11-07
Compounds Grant 10,435,391 - Casillas , et al. O	2019-10-08
Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists Grant 10,385,039 - Brown , et al. A	2019-08-20
Conjugates Comprising Ripk2 Inhibitors App 20190119271 - CASILLAS; Linda N. ; et al.	2019-04-25
Bicyclic Aza Compounds As Muscarnic M1 Receptor And/or M4 Receptor Antagonists App 20190112294 - Brown; Giles Albert ; et al.	2019-04-18
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists Grant 10,196,380 - Brown , et al. Fe	2019-02-05
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists App 20180179184 - Brown; Giles Albert ; et al.	2018-06-28
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists Grant 9,926,297 - Brown , et al. March 27, 2	2018-03-27
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists App 20170240530 - Brown; Giles Albert ; et al.	2017-08-24
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists Grant 9,670,183 - Brown , et al. June 6, 2	2017-06-06
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists App 20170015650 - Brown; Giles Albert ; et al.	2017-01-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.